03131nam a2200277 4500 384276 9291680567 384276 20070514d2001 y0pory50 ba eng Modelling drug use methods to quantify and understand hidden processes European Monitoring Centre for Drugs and Drug Addiction, EMCDDA Luxembourg Office for Official Publications of the European Communities 2001 245 p. 24 cm EMCDDA Scientific Monograph Series 6 Foreword (Georges Estievenart). General introduction (Lucas Wiessing; Richard Hartnoll). Part I - What is modelling and how can it be used?: Introduction. Chapter 1 - Epidemiology of drug use at macro level: indicators, models and policy-making (Lucas Wiessing, Richard Hartnoll; Carla Rossi). Chapter 2 - What are dynamic models and how can they be used? (Christine Godfrey; Steve Parrot; Mathew Sutton; Vanessa Waby; Philip Young and Catherine Comiskey; Martin Frischer; Gordon Hay; Mathew Hickman; Johannes Jager; James Kahan; Ludwig Kraus; Roberto Mollica; Maarten Postma; Roland Simon; Colin Tayçor; Lucas Wiessing). Part II - Modelling drug use with available data: Introduction. Chapter 3 - Modelling drug misuse in Europe using geographic information systems (Martin Frischer; Heath Heatlie). Chapter 4 - Using available data with dynamic models to estimate the extent of problem drug use (Carla Rossi). Chapter 5 - Multiple-indicator models (Roberto Mollica and Fabio Mariani). Part III - Modelling techniques and their uses: Introduction. Chapter 6 - The method of back calculation as a means of estimating incidence (Catherine Comiskey; Gordon Hay). Chapter 7 - Compartment modelling and stochastic dynamic systems (Gordon Hay; Catherine Comiskey). Chapter 8 - Dynamic models in drug epidemiology (Colin Taylor; Philip Young). Chapter 9 - Structural equations and path analyses: using multiple indicators of drug prevalence (Colin Taylor; Philip Young). Part IV - Modelling the health consequences of drug use: Introduction. Chapter 10 - Modelling infectious diseases and other health consequences: predicting future morbidity consequences and spread of HIV, hepatitis B and hepatitis C. (Mirjam Kretzschmar). Chapter 11 - Developing multinational scenario analyses of health impacts of drug use (Johanes C. Jager; Maarten J. Postma; Peter W. Achterberg). Part V - Economic Models: Introduction. Chapter 12 - Modelling the health-care costs of drug-use-related disease (Maarten J. Postma; Keith Tolley; Johannes C. Jager). Chapter 13 – Economic market models (Matthew Sutton). General conclusions (Richard Hartnoll; Lucas Wiessing). Contributors. DROGA 228142 PREVENÇÃO DA TOXICODEPENDÊNCIA 103892 METODOLOGIAS 341295 ESTATÍSTICAS SOBRE DROGA 344136 OEDT 321506 UNIÃO EUROPEIA 224774 EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION 351987 Oferta 0 PJ_19_000000000000000_D_64 2022-06-06 PJ28029 414152 PJ PJ PJ128029 PJ19.D.64 2022-06-06 0 MO Oferta